Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
tandemdiabetes.com

See what CB Insights has to offer

Founded Year

2006

Stage

IPO | IPO

Total Raised

$92.81M

Date of IPO

11/14/2013

Market Cap

7.87B

Stock Price

123.69

Revenue

$0000 

About Tandem Diabetes Care

Tandem Diabetes Care is dedicated to advancing the management of diabetes through new technologies, offering a user-centric and integrated approach to product design, development, and customer care.

Tandem Diabetes Care Headquarter Location

11075 Roselle St

San Diego, California, 92121,

United States

858-366-6900

Latest Tandem Diabetes Care News

Tandem Diabetes on the rise after Wells Fargo upgraded on sales prospects

Jan 19, 2022

Pgiam/iStock via Getty Images Following a four-day skid, Tandem Diabetes Care ( TNDM +6.9%) is trading higher after Wells Fargo upgraded the insulin pump maker to Overweight from Equal Weight, citing several reasons for the company to post better than expected financials over the next few years. “We see upside potential to our outside the US sales in 2022,” the analysts led by Larry Biegelsen wrote, noting that 2022 will be the first full year Tandem’s (NASDAQ: TNDM ) Control IQ technology will be available in France and Germany. In addition to a strong renewal cycle starting this year, the team also attributes the sales upside to the potential delays to the rival devices from Medtronic (NYSE: MDT ) and Insulet (NASDAQ: PODD ) for their 780G and Omnipod 5 insulin pumps, respectively. The price target raised to $160 from $137 per share indicates a premium of ~37.7% to the last close. Read: In December, Wells Fargo downgraded Medtronic ( MDT ) after an FDA warning letter dealt a blow to the company’s diabetes business. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tandem Diabetes Care

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tandem Diabetes Care is included in 2 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

M

Medical Devices

3,607 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

Tandem Diabetes Care Patents

Tandem Diabetes Care has filed 175 patents.

The 3 most popular patent topics include:

  • Insulin therapies
  • Diabetes
  • Implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/10/2019

1/18/2022

Diabetes, Insulin therapies, G protein coupled receptors, Peptide hormones, Medical equipment

Grant

Application Date

10/10/2019

Grant Date

1/18/2022

Title

Related Topics

Diabetes, Insulin therapies, G protein coupled receptors, Peptide hormones, Medical equipment

Status

Grant

Tandem Diabetes Care Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Tandem Diabetes Care Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.